TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TNXP stock results show that Tonix Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace